Ca2+-Dependent, Fas- And Perforin-Independent Apoptotic Death of Allografted Tumor Cells by a Type of Activated Macrophage

Journal of Immunology

Volumn 159, Issue 1, 1997, Pages 15-21

  Yoshida, Ryotaro ^a   Sanchez Bueno, Antonio ^b   Yamamoto, Naoki ^b   Einaga Naito, Kuniko ^b  

^a OSAKA BIOSCIENCE INSTITUTE   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; FAS LIGAND; FASL PROTEIN, MOUSE; MEMBRANE PROTEIN; PERFORIN; PORE FORMING CYTOTOXIC PROTEIN;

ALLOTRANSPLANTATION; ANIMAL; APOPTOSIS; ARTICLE; C3H MOUSE; C57BL MOUSE; CANCER TRANSPLANTATION; CELL COMMUNICATION; CELLULAR IMMUNITY; EXPERIMENTAL NEOPLASM; FIBROSARCOMA; IMMUNOLOGY; MACROPHAGE; MACROPHAGE ACTIVATION; MALE; MOUSE; PATHOLOGY;

ANIMALS; APOPTOSIS; CALCIUM; CELL COMMUNICATION; FAS LIGAND PROTEIN; FIBROSARCOMA; IMMUNITY, CELLULAR; MACROPHAGE ACTIVATION; MACROPHAGES; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; PORE FORMING CYTOTOXIC PROTEINS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0031179007     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Henkart, P. A. 1985. Mechanism of lymphocyte-mediated cytotoxicity. Annu. Rev. Immunol. 3:31.
2. Kägi, D., B. Ledermann, K. Bürki, P. Seiler, B. Odermatt, K. J. Olsen, E. R. Podack, R. M. Zinkernagel, and H. Hengartner. 1994. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 369:31.
3. 2+-independent T cell-mediated cytotoxicity. J. Exp. Med. 177:195.
4. Yonehara, S., A. Ishii, and M. Yonehara. 1989. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-down-regulated with the receptor of tumor necrosis factor. J. Exp. Med. 169:1747.
5. Suda, T., T. Takahashi, P. Golstein, and S. Nagata. 1993. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75:1169.
6. Lowin, B., M. Hahne, C. Mattmann, and J. Tschopp. 1994. Cytotoxic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature 370:650.
7. Kägi, D., F. Vignaux, B. Ledermann, K. Bürki, V. Depraetere, S. Nagata, H. Hengartner, and P. Golstein. 1994. Fas and perform pathways as major mechanisms of T cell-mediated cytotoxicity. Science 265:528.
8. Hall, B. M. 1991. Cells mediating allograft rejection. Transplantation 51:1141.
9. Sprent, J., M. Schaefer, D. Lo., and R. Korngold. 1986. Properties of purified T cell subsets. II. In vivo responses to class I vs. class II H-2 differences. J. Exp. Med. 163:998.
10. Rosenberg, A. S., T. Mizuochi, and A. Singer. 1986. Analysis of T-cell subsets in rejection of Kb mutant skin allografts differing in class I MHC. Nature 322:829.
11. Ichikawa, T., E. Nakayama, A. Uenaka, M. Monden, and T. Mori. 1987. Effector cells in allelic H-2 class I-incompatible skin graft rejection. J. Exp. Med. 166:982.
12. Gracie, J. R., E. M. Bolton, C. Porteus, and J. A. Bradley. 1990. T cell requirements for the rejection of renal allografts bearing an isolated class I MHC disparity. J. Exp. Med. 172:1547.
13. + T cell-mediated rejection of major histocompatibility complex class I-disparate grafts: a role for alloantibody. Eur. J. Immunol. 23:2078.
14. Loveland, B. E., R. M. Hogath, R. H. Ceredig, and I. F. C. Mckenzie. 1981. Cells mediating graft rejection in the mouse. I. Lyt-l cells mediate skin rejection. J. Exp. Med. 153:1044.
15. +-2, 3-positive T cells in murine skin graft rejection. J. Exp. Med. 159:57.
16. + cell subsets. Transplantation 41:634.
17. Rosenberg, A. S., T. Mizouchi, S. O. Sharrow, and A. Singer. 1987. Phenotype specificity and function of T cell subsets and T cell interactions involved in skin allograft rejection. J. Exp. Med. 165:1296.
18. 2-microglobulin-deficient mice. J. Exp. Med. 175:885.
19. + lymphocytes from CD8 -/- mice are sufficient to mediate the rejection of MHC class II or class I disparate skin grafts. J. Immunol. 156:4114.
20. + T cell populations. Transplantation 62:300.
21. + cells are essential for allorejection. J. Exp. Med. 184:2013.
22. Yoshida, R., O. Takikawa, T. Oku, and A. Habara-Ohkubo. 1991. Mononuclear phagocytes: a major population of effector cells responsible for rejection of allografted tumor cells in mice. Proc. Natl. Acad. Sci. USA 88:1526.
23. Yoshida, R., A. Matsuura, K. Einaga, Y. Ushio, N. Yamamoto, and Y. Yoneda. 1997. Two distinct populations of primary cytotoxic cells infiltrating into allografted tumor rejection sites: infiltration of macrophages cytotoxic against allografted tumor precedes that of multiple sets of cylotoxic T lymphocytes with distinct specificity to alloantigens. Microbiol. Immunol. 41:149.
24. Sanchez-Bueno, A., V. Verkhusha, Y. Tanaka, O. Takikawa, and R. Yoshida. 1996. Interferon-γ-dependent expression of inducible nitric oxide synthase, interleukin-12, and interferon-γ-inducing factor in macrophages elicited by allografted tumor cells. Biochem. Biophys. Res. Commun. 224:555.
25. Ushio, Y., N. Yamamoto, A. Sanchez-Bueno, and R. Yoshida. 1996. Failure to reject an allografted tumor after elimination of macrophages in mice. Microbiol. Immunol. 40:489.
26. Takikawa, O., T. Oku, N. Ito, Y. Ushio, N. Yumamoto, Y. Yoneda, J. Tsuji, A. Sanchez-Bueno, V. Verkhusha, and R. Yoshida. 1996. Multiple expression of Ly-6C and accumulation of a Ly-6C premRNA in activated macrophages involved in rejection of an allografted tumor. Biochem. Biophys. Res. Commun. 226:247.
27. Yoshida, R., S. W. Park, H. Yasui, and O. Takikawa. 1988. Tryptophan degradation in transplanted tumor cells undergoing rejection. J. Immunol. 141:2819.
28. Takikawa, O., A. Habara-Ohkubo, and R. Yoshida. 1990. IFN-γ is the inducer of indoleamine 2.3-dioxygenase in allografted tumor cells undergoing rejection. J. Immunol. 145:1246.
29. Takikawa, O., T. Oku, H. Yasui, and R. Yoshida. 1993. Synergism between IFN-γ and IL-1α/β in growth inhibition of an allografted tumor. J. Immunol. 151:2070.
30. Ascher, N. L., R. Hoffman, S. Chen, and R. L. Simmons. 1980. Specific and nonspecific infiltration of sponge matrix allografts by specially sensitized cytotoxic lymphocytes. Cell. Immunol. 52:38.
31. Cui, S., S. Reichner, R. M. Mateo, and J. E. Albina. 1994. Activated murine macrophages induce apoptosis in tumor cells through nitric oxide-dependent or-independent mechanisms. Cancer Res. 54:2462.
32. Watanabe-Fukunaga, R., C. I. Brannan, N. G. Copeland, N. A. Jenkins, and S. Nagata. 1992. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356:314.
33. Kojima, H., N. Shinohara, S. Hanaoka, Y. Someya-Shirota, Y. Takagi, H. Ohno, T. Saito, T. Katayama, H. Yagita, K. Okumura, Y. Shinkai, F. W. Alt, A. Matsuzawa, S. Yonehara, and H. Takayama. 1994. Two distinct pathways of specific killing revealed by perforin mutant cytotoxic T lymphocytes. Immunity 1:357.
34. Watanabe, D., T. Suda, H. Hashimoto, and S. Nagata. 1995. Constitutive activation of the Fas ligand gene in mouse lymphoproliferative disorders. EMBO J. 14:12.
35. Takahashi, T., M. Tanaka, C. I. Brannan, N. A. Jenkins, N. G. Copeland, T. Suda, and S. Nagata. 1994. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76:969.
36. Young, J. E., and Z. A. Cohn. 1987. Cellular and humoral mechanisms of cytotoxicity: structural and functional analogies. Adv. Immunol. 41:269.
37. Krams, S. M., H. Egawa, M. B. Quinn, J. C. Villanueva, R. Garcia-Kennedy, and O. M. Martinez. 1995. Apoptosis as a mechanism of cell death in liver allograft rejection. Transplantation 59:621.
38. Matsuno, T., H. Sasaki, N. Ishido, K. Nakagawa, T. Ishikawa, A. Oishi, M. Inugaki, S. Saito, T. Yagi, M. Haisa, N. Tanaka, and K. Orita. 1996. A poptosis in human kidney allografts. Transplant. Proc. 28:1226.
39. + cytotoxic T cells. Proc. Natl. Acad. Sci. USA 91:4185.
40. Garner, R., C. D. Helgason, E. A. Atkinson, M. J. Pinkoski, H. L. Ostergaard, O. Sorensen, A. Fu, P. H. Lapchk, A. Rabinovitch, J. E. McElhaney, G. Berke, and R. C. Bleackley. 1994. Characterization of a granule-independent lytic mechanism used by CTL hybridomas. J. Immunol. 153:5413.
41. Anel, A., G. V. Richieri, and A. M. Kleinfeld. 1994. A tyrosine phosphorylation requirement for cytoioxic T lymphocyte degranulation. J. Biol. Chem. 269:9506.
42. Lowin, B., C. Matlman, M. Hahne, and J. Tschopp. 1996. Comparison of Fas (Apo-1/CD95)- and perforin-mediated cytotoxicity in primary T lymphocytes. Int. Immunol. 8:57.
43. Hanubuchi, S., M. Koyanugi, A. Kawasaki, N. Shinohara, A. Matsuzawa, Y. Nishimura, Y. Kohayash, S. Yonehara, H. Yagita, and K. Okumura. 1994. Fas and its ligand in a general mechanism of T-cell mediated cytotoxicity. Proc. Natl. Acad. Sci. USA 91:4930.
44. Ju, S. T. 1991. Distinct pathways of CD4 and CD8 cells induce rapid target DNA fragmentation. J. Immunol. 146:812.
45. Strack, P., C. Martin, S. Saito, R. H. Dekruyff, and S. T. Ju. 1990. Metabolic inhibitors distinguish cytolytic activity of CD4 and CD8 clones. Eur. J. Immunol. 20:179.
46. + T cell-mediated cytotoxicity. J. Immunol. 152:1127.
47. Schulz, M., H-J. Schuurman, J. Joergensen, C. Steiner, T. Meerloo, D. Kägi, H. Hengartner, R. M. Zinkernagel, M. H. Schreiber, K. Bürki, and B. Ledermann. 1995. Acute rejection of vascular heart allografts by perforin-deficient mice. Eur. J. Immunol. 25:474.
48. Balazs, E. A., L. Z. Toth, and V. Ozanics. 1980. Cytological studies on the developing vitreous to the hyaloid vessel system. Arch. Ophthalmol. 213:71.
49. Latker, C. H., and T. Kuwabara. 1981. Regression of the tunica vasculosa lentis in the postnatal rat. Invest. Ophthalmol. Vis. Sci. 21:689.
50. Lang, R. A., and J. M. Bishop. 1993. Macrophages are required for cell death and tissue remodeling in the developing mouse eye. Cell 74:453.
51. Lang, R., M. Lusting, F. Francois, M. Sellinger, and H. Plesken. 1994. Apoptosis during macrophage-dependent ocular tissue remodelling. Development 120:3395.